Osteonecrosis due to drugs, pelvis
ICD-10 M87.150 is a billable code used to indicate a diagnosis of osteonecrosis due to drugs, pelvis.
Osteonecrosis due to drugs, particularly in the pelvis, is a condition characterized by the death of bone tissue due to a lack of blood supply, often precipitated by the use of certain medications. Commonly implicated drugs include corticosteroids and bisphosphonates, which can disrupt normal bone remodeling processes. The pelvis is a critical weight-bearing area, and osteonecrosis here can lead to significant pain, mobility issues, and potential fractures. Patients may present with hip pain, limited range of motion, and symptoms that mimic arthritis. Diagnosis typically involves imaging studies such as MRI or X-rays, which can reveal characteristic changes in bone density and structure. Early detection is crucial to prevent further complications, including the need for surgical interventions like joint replacement. Management may include discontinuation of the offending drug, pain management, and in some cases, surgical procedures to restore blood flow to the affected area.
Detailed history of medication use, imaging results, and clinical findings.
Patients presenting with hip pain and a history of corticosteroid use.
Need for clear documentation of the relationship between drug use and osteonecrosis.
Comprehensive medication history, including duration and dosage of drugs.
Patients with autoimmune conditions on long-term corticosteroids presenting with joint pain.
Understanding the impact of underlying conditions on bone health.
Used for pain management in patients with osteonecrosis.
Document the indication for the procedure and any imaging performed.
Orthopedic specialists may perform this procedure to relieve symptoms.
Corticosteroids and bisphosphonates are the most commonly associated medications, but other drugs may also contribute to the risk of osteonecrosis.
